EMA advises clinical trial managers over impact of war in Ukraine
![Employees at a Ukrainian hospital in Trostyanets say Russian forces have attacked the hospital during its siege of the city | Photo: Thomas Peter/REUTERS / X90176](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13880053.ece/ALTERNATES/schema-16_9/doc7kcy6z8mdupgf8657e2.jpg)
Russia’s invasion of Ukraine has been the cause of many disruptions in the region at large, and there is now also a great chance of clinical trials being impacted, according to the European Medicines Agency (EMA).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.